Source: PR Newswire

Press Release: PSG : Trends in Drug Benefit Design Report Released by Pharmaceutical Strategies Group

Highlights plan sponsors' strategies to address changing environment DALLAS, June 13, 2023 /PRNewswire/ -- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the launch of its Trends in Drug Benefit Design Report. The report delivers innovative research on the...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Dave Borden's photo - CEO of PSG

CEO

Dave Borden

CEO Approval Rating

90/100

Read more